About the Landscape Review

Using data derived from Beacon ADC, The H1 2023 ADC Landscape Review keeps you ahead of the curve with contextual updates and highlights from the dynamic world of ADC development. Don’t miss out on important insights for your drug development strategies.

The Review covers:

  • The Trial Landscape – trial development highlights, such as the phase of new trials, drugs being investigated in trials, trial status changes, a list of all completed trials of clinically active ADCs, and a list of all terminated/withdrawn/suspended FIH (first in human) trials.
  • ADC Deals – a complete list of every ADC deal so far in 2023. This list includes the deal date, the type of deal such as license agreement, collaboration, option agreement, acquisition, investment, a summary, and a link to the original source.
  • The Drug Landscape – update your knowledge of drug development by geographic location, ADCs entering and exiting the clinic, a list of every ADC entering the clinic, MoA (mechanism of action) and payloads, top targets, and an outline of the 10 drugs that have progressed to higher development stages so far this year.

Please note that some information has been removed from the downloadable content below. If you would like to receive the complete version and speak with one of our specialists in ADC drugs and trials, please do not hesitate to contact beacon@hansonwade.com to discuss your drug development data needs.

Beacon ADC customers, please log in to Beacon and go to the Analysis tab to download your complete version.

The Beacon ADC H1 2023 Landscape Review

The H1 2023 Landscape Review


Beacon ADC

How the most complete ADC database can help you

What we cover

Beacon ADC is a manually curated database solution that includes clinical trial and drug records for preclinical, active, approved and discontinued:

  • ADC (Antibody Drug Conjugates)
  • Immunotoxins
  • SMDCs (Small Molecule Drug Conjugates)
  • Radioimmunoconjugates
  • Ligand Conjugated Nanoparticles
  • Liposomal Drug Conjugate and other comparable modalities

How Beacon ADC works

Search the trial and drug landscape by linker, payload and target alongside 20 other search criteria including disease, line of therapy, biomarker, sponsor etc. Instantly extract the data points you need to conduct more complex analysis.

Find out more


Beacon is the essential decision-support tool for developers of complex therapeutics. Our market-defining, proprietary ontologies, combined with the most accurate and comprehensive life sciences data, provide our customers with unparalleled visibility of the drug and trial landscape.

With Beacon, you can make drug development decisions with confidence. This is why 23 of the world’s top 25 drug developers trust us.

Discover a database tailored to your needs

At Beacon, we are committed to empowering our pharmaceutical and biotech industry partners with accurate, comprehensive data. We are not just a tool; we see ourselves as a partner in the drug development journey. Contact us to learn how we help you.

    Raj Kumar

Get Started